Clinical Trials

A Phase 2, Fast Real-time Assessment of Combination Therapies in Immuno-ONcology Study in Participants with Advanced Gastric Cancer (FRACTION-Gastric Cancer)


Study ID
Bristol-Myers Squibb CA018-003

NCT Number
NCT02935634 (Click on the NCT number for more information about the trial)

Research Study Number
2016-0576

Principle Investigator
Dr. Martin Gutierrez

Phase
II

Sponsor
Bristol-Myers Squibb


Other protocol defined inclusion/exclusion criteria could apply If you are a physician and would like more details about this study, please contact us at JTCCResearch@HackensackMeridian.org

Apply Now